TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives $11.56 Consensus Target Price from Brokerages
Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) have earned an average recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat.com reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1 year […]
Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) have earned an average recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat.com reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1 year […]
